Objective
- Determine concentration of ADA prepared Oct. 23 via Bradford Assay
Bradford Assay
- Solutions were prepared with 715μL 1x Bio-Rad Bradford reagant and the following concentrations of BSA:
| volume BSA (uL)
| volume H2O (uL
| [BSA] (mg/mL)
| [BSA] (M)
|
| 0 | 30 | 0 | 0.00E+00
|
| 5 | 25 | 0.24 | 3.61E-06
|
| 10 | 20 | 0.15 | 2.26E-06
|
| 15 | 15 | 0.13 | 2.01E-06
|
| 20 | 10 | 0.15 | 2.26E-06
|
| 25 | 5 | 0.24 | 3.61E-06
|
| 30 | 0 | 1 | 1.51E-05
|
- A UV/Vis calibration curve was obtained by analyzing the samples and plotting BSA concentration against absorbance at 595nm.
- The ADA purified yesterday, labelled Frac 9, was analyzed along with Fracs 2 and 8 purified 9/26 via UV/Vis and it's peak was compared to the linear regression of BSA's in order to determine concentration.
Data
| Fraction #
| Absorbance
| [ADA] [mg/mL]
| molar absorptivity [mL/mg*cm-1]
| Molarity (µM)
|
| 2 | 0.93 | 0.0177 | 52.4 | 42.0
|
| 8 | 0.757 | 0.0115 | 65.9 | 54.4
|
| 9 | 0.819 | 0.0137 | 59.7 | 65.0
|
|
|
Frac 2 was found to be 42µM, while 8 was 54.4µM and 9 was 65µM.
|